The relationship between visit-to-visit variability in blood pressure and incidence of metabolic syndrome: a general population-based cohort study in Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Previous studies demonstrated that visit-to-visit variability of blood pressure (BP) has significant relationship with cardiovascular disease. Visit-to-visit variability in BP might have prognostic value for cardiovascular disease. The aim of this study is to evaluate the effect of visit-to-visit variability in BP on development of metabolic syndrome in general population without cardiovascular disease, diabetes mellitus, metabolic syndrome, and BP medication. Method: We used data from the Korean Genome Epidemiology Study conducted by the Korean Centers for Disease Control and Prevention. All cohorts who were followed first 3 periods formed the basis of the study sample, which consisted of 7195 people. Of these samples, 3431 subjects who had cardiovascular disease, diabetes mellitus, or metabolic syndrome were excluded, and 312 subjects who were using antihypertensive medication in first 3 periods were excluded. Our final study sample consisted of 3452 cohorts. Results: The mean age was 53.5 (8.25) years. The proportion of male was 50.2%. Average follow-up duration was 5.91 (0.17) years. In generalized estimating equation, the development of metabolic syndrome was associated with mean systolic BP (SBP) (Odd ratio (OR) 1.042, 95% confidence interval (CI) 1.035–1.048, p < 0.001), mean diastolic BP (DBP) (OR 1.058, 95% CI 1.049–1.069, p < 0.001), standard deviation (SD) of SBP (OR 1.036, 95% CI 1.017–1.055, p < 0.001), SD of DBP (OR 1.053, 95% CI 1.027–1.080, p < 0.001), and coefficient of variation (CV) of DBP (OR 1.025, 95% CI 1.005–1.046, p = 0.016) after adjusted for age, sex, and metabolic syndrome component. When mean SBP, mean DBP, SBP variability, and DBP variability were entered all together in the analysis model, SD of DBP (OR 1.033, 95% CI 1.003–1.063, p = 0.030) and CV of DBP (OR 1.027, 95% CI 1.004–1.051, p = 0.020) were significantly associated with the development of metabolic syndrome. Conclusion: In general population without cardiovascular disease, diabetes mellitus, metabolic syndrome, and BP medication, SD of DBP and CV of DBP was associated with the development of metabolic syndrome. Visitto-visit variability in DBP might be helpful for the prediction of future metabolic syndrome development.
Abstract
Background: Previous studies demonstrated that visit-to-visit variability of blood pressure (BP) has significant relationship with cardiovascular disease. Visit-to-visit variability in BP might have prognostic value for cardiovascular disease. The aim of this study is to evaluate the effect of visit-to-visit variability in BP on development of metabolic syndrome in general population without cardiovascular disease, diabetes mellitus, metabolic syndrome, and BP medication. Method: We used data from the Korean Genome Epidemiology Study conducted by the Korean Centers for Disease Control and Prevention. All cohorts who were followed first 3 periods formed the basis of the study sample, which consisted of 7195 people. Of these samples, 3431 subjects who had cardiovascular disease, diabetes mellitus, or metabolic syndrome were excluded, and 312 subjects who were using antihypertensive medication in first 3 periods were excluded. Our final study sample consisted of 3452 cohorts. Results: The mean age was 53.5 (8.25) years. The proportion of male was 50.2%. Average follow-up duration was 5.91 (0.17) years. In generalized estimating equation, the development of metabolic syndrome was associated with mean systolic BP (SBP) (Odd ratio (OR) 1.042, 95% confidence interval (CI) 1.035–1.048, p < 0.001), mean diastolic BP (DBP) (OR 1.058, 95% CI 1.049–1.069, p < 0.001), standard deviation (SD) of SBP (OR 1.036, 95% CI 1.017–1.055, p < 0.001), SD of DBP (OR 1.053, 95% CI 1.027–1.080, p < 0.001), and coefficient of variation (CV) of DBP (OR 1.025, 95% CI 1.005–1.046, p = 0.016) after adjusted for age, sex, and metabolic syndrome component. When mean SBP, mean DBP, SBP variability, and DBP variability were entered all together in the analysis model, SD of DBP (OR 1.033, 95% CI 1.003–1.063, p = 0.030) and CV of DBP (OR 1.027, 95% CI 1.004–1.051, p = 0.020) were significantly associated with the development of metabolic syndrome. Conclusion: In general population without cardiovascular disease, diabetes mellitus, metabolic syndrome, and BP medication, SD of DBP and CV of DBP was associated with the development of metabolic syndrome. Visitto-visit variability in DBP might be helpful for the prediction of future metabolic syndrome development.
참고문헌 (24)
- Suchy-Dicey AM, "Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study", Am J Hypertens, 26(10), pp.1210~1217 (2013)
- Vishram JK, "Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage : a LIFE substudy", J Hypertens, 33(12), pp.2422~2430 (2015)
- Rossignol P, "Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients : insights from the HEAAL study", Int J Cardiol, 187, pp.183~189 (2015)
- Grove JS, "Variability in systolic blood pressure--a risk factor for coronary heart disease?", Am J Epidemiol, 145(9), pp.771~776 (1997)
- Webb AJ, "Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke : a systematic review and meta-analysis", Lancet, 375(9718), pp.906~915 (2010)
- Rothwell PM, "Effects of ß blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke", Lancet Neurol, 9(5), pp.469~480 (2010)
- Muntner P, "The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population findings from NHANES III, 1988 to 1994", Hypertension, 57(2), pp.160~166 (2011)
- Mottillo S, "The metabolic syndrome and cardiovascular risk : a systematic review and meta-analysis", J Am Coll Cardiol, 56(14), pp.1113~1132 (2010)
- Gami AS, "Metabolic syndrome and risk of incident cardiovascular events and death : a systematic review and meta-analysis of longitudinal studies", J Am Coll Cardiol, 49(4), pp.403~414 (2007)
- Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association", National Heart, Lung, and Blood Institute scientific statement, 2005, pp.112(17), 2735~2752
- Hsieh YT, "Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5.5-year prospective analysis", Eur J Clin Investig, 42(3), pp.245~253 (2012)
- Okada H, "Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes", Diabetes Care, 36(7), pp.1908~1912 (2013)
- Okada H, "Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes", Atherosclerosis, 220(1), pp.155~159 (2012)
- Franklin SS, "Predictors of new-onset diastolic and systolic hypertension : the Framingham heart study", Circulation, 111(9), pp.1121~1127 (2005)
- Liu F, "Prevalence of isolated diastolic hypertension and associated risk factors among different ethnicity groups in Xinjiang, China", PLoS One, 10(12), pp.e0145325~ (2015)
- Franklin SS, "Hemodynamic patterns of age-related changes in blood pressure. The Framingham heart study", Circulation, 96(1), pp.308~315 (1997)
- Li Y, "Cardiovascular risks associated with diastolic blood pressure and isolated diastolic hypertension", Curr Hypertens Rep, 16(11), pp.489~ (2014)
- Nagai M, "Visit-to-visit blood pressure variations : new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease", J Am Soc Hypertens, 5(3), pp.184~192 (2011)
- Shimbo D, "Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability : the multi-ethnic study of atherosclerosis(MESA)", Am J Hypertens, 26(7), pp.896~902 (2013)
- Salomaa V, "Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC study. Atherosclerosis risk in communities study", Circulation, 91(5), pp.1432~1443 (1995)
- Urbina EM, "Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus", J Hypertens, 28(8), pp.1692~1698 (2010)
- Rothwell PM, "Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension", Lancet, 375(9718), pp.938~948 (2010)
- Rothwell PM, "Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension", Lancet, 375(9718), pp.895~905 (2010)
- Faramawi MF, "Obesity is associated with visit-to-visit systolic blood pressure variability in the US adults", J Public Health(Oxf), 37(4), pp.694~700 (2015)